Cargando…
The Impact of COVID-19 Pandemic on Adult and Pediatric Allergy & Immunology Services in the UK National Health Service
BACKGROUND: The coronavirus disease 2019 pandemic imposed multiple restrictions on health care services. OBJECTIVE: To investigate the impact of the pandemic on Allergy & Immunology (A&I) services in the United Kingdom. METHODS: A national survey of all A&I services registered with the R...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703386/ https://www.ncbi.nlm.nih.gov/pubmed/33271350 http://dx.doi.org/10.1016/j.jaip.2020.11.038 |
_version_ | 1783616627312427008 |
---|---|
author | Krishna, Mamidipudi Thirumala Beck, Sarah Gribbin, Nathan Nasser, Shuaib Turner, Paul J. Hambleton, Sophie Sargur, Ravishankar Whyte, Andrew Bethune, Claire |
author_facet | Krishna, Mamidipudi Thirumala Beck, Sarah Gribbin, Nathan Nasser, Shuaib Turner, Paul J. Hambleton, Sophie Sargur, Ravishankar Whyte, Andrew Bethune, Claire |
author_sort | Krishna, Mamidipudi Thirumala |
collection | PubMed |
description | BACKGROUND: The coronavirus disease 2019 pandemic imposed multiple restrictions on health care services. OBJECTIVE: To investigate the impact of the pandemic on Allergy & Immunology (A&I) services in the United Kingdom. METHODS: A national survey of all A&I services registered with the Royal College of Physicians and/or the British Society for Allergy and Clinical Immunology was carried out. The survey covered staffing, facilities, personal protective equipment, appointments & patient review, investigations, treatments, and research activity. Weeks commencing February 3, 2020 (pre–coronavirus disease), April 6, 2020, and May 8, 2020, were used as reference points for the data set. RESULTS: A total of 99 services participated. There was a reduction in nursing, medical, administrative, and allied health professional staff during the pandemic; 86% and 92% of A&I services continued to accept nonurgent and urgent referrals, respectively, during the pandemic. There were changes in immunoglobulin dose and infusion regimen in 67% and 14% of adult and pediatric services, respectively; 30% discontinued immunoglobulin replacement in some patients. There was a significant (all variables, P ≤ .0001) reduction in the following: face-to-face consultations (increase in telephone consultations), initiation of venom immunotherapy, sublingual and subcutaneous injection immunotherapy, anesthetic allergy testing, and hospital procedures (food challenges, immunoglobulin and omalizumab administration); and a significant increase (P ≤ .0001) in home therapy for immunoglobulin and omalizumab. Adverse clinical outcomes were reported, but none were serious. CONCLUSIONS: The pandemic had a significant impact on A&I services, leading to multiple unplanned pragmatic amendments in service delivery. There is an urgent need for prospective audits and strategic planning in the medium and long-term to achieve equitable, safe, and standardized health care. |
format | Online Article Text |
id | pubmed-7703386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Academy of Allergy, Asthma & Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-77033862020-12-01 The Impact of COVID-19 Pandemic on Adult and Pediatric Allergy & Immunology Services in the UK National Health Service Krishna, Mamidipudi Thirumala Beck, Sarah Gribbin, Nathan Nasser, Shuaib Turner, Paul J. Hambleton, Sophie Sargur, Ravishankar Whyte, Andrew Bethune, Claire J Allergy Clin Immunol Pract Original Article BACKGROUND: The coronavirus disease 2019 pandemic imposed multiple restrictions on health care services. OBJECTIVE: To investigate the impact of the pandemic on Allergy & Immunology (A&I) services in the United Kingdom. METHODS: A national survey of all A&I services registered with the Royal College of Physicians and/or the British Society for Allergy and Clinical Immunology was carried out. The survey covered staffing, facilities, personal protective equipment, appointments & patient review, investigations, treatments, and research activity. Weeks commencing February 3, 2020 (pre–coronavirus disease), April 6, 2020, and May 8, 2020, were used as reference points for the data set. RESULTS: A total of 99 services participated. There was a reduction in nursing, medical, administrative, and allied health professional staff during the pandemic; 86% and 92% of A&I services continued to accept nonurgent and urgent referrals, respectively, during the pandemic. There were changes in immunoglobulin dose and infusion regimen in 67% and 14% of adult and pediatric services, respectively; 30% discontinued immunoglobulin replacement in some patients. There was a significant (all variables, P ≤ .0001) reduction in the following: face-to-face consultations (increase in telephone consultations), initiation of venom immunotherapy, sublingual and subcutaneous injection immunotherapy, anesthetic allergy testing, and hospital procedures (food challenges, immunoglobulin and omalizumab administration); and a significant increase (P ≤ .0001) in home therapy for immunoglobulin and omalizumab. Adverse clinical outcomes were reported, but none were serious. CONCLUSIONS: The pandemic had a significant impact on A&I services, leading to multiple unplanned pragmatic amendments in service delivery. There is an urgent need for prospective audits and strategic planning in the medium and long-term to achieve equitable, safe, and standardized health care. American Academy of Allergy, Asthma & Immunology 2021-02 2020-11-30 /pmc/articles/PMC7703386/ /pubmed/33271350 http://dx.doi.org/10.1016/j.jaip.2020.11.038 Text en © 2020 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Krishna, Mamidipudi Thirumala Beck, Sarah Gribbin, Nathan Nasser, Shuaib Turner, Paul J. Hambleton, Sophie Sargur, Ravishankar Whyte, Andrew Bethune, Claire The Impact of COVID-19 Pandemic on Adult and Pediatric Allergy & Immunology Services in the UK National Health Service |
title | The Impact of COVID-19 Pandemic on Adult and Pediatric Allergy & Immunology Services in the UK National Health Service |
title_full | The Impact of COVID-19 Pandemic on Adult and Pediatric Allergy & Immunology Services in the UK National Health Service |
title_fullStr | The Impact of COVID-19 Pandemic on Adult and Pediatric Allergy & Immunology Services in the UK National Health Service |
title_full_unstemmed | The Impact of COVID-19 Pandemic on Adult and Pediatric Allergy & Immunology Services in the UK National Health Service |
title_short | The Impact of COVID-19 Pandemic on Adult and Pediatric Allergy & Immunology Services in the UK National Health Service |
title_sort | impact of covid-19 pandemic on adult and pediatric allergy & immunology services in the uk national health service |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703386/ https://www.ncbi.nlm.nih.gov/pubmed/33271350 http://dx.doi.org/10.1016/j.jaip.2020.11.038 |
work_keys_str_mv | AT krishnamamidipudithirumala theimpactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT becksarah theimpactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT gribbinnathan theimpactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT nassershuaib theimpactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT turnerpaulj theimpactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT hambletonsophie theimpactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT sargurravishankar theimpactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT whyteandrew theimpactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT bethuneclaire theimpactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT krishnamamidipudithirumala impactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT becksarah impactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT gribbinnathan impactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT nassershuaib impactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT turnerpaulj impactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT hambletonsophie impactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT sargurravishankar impactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT whyteandrew impactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice AT bethuneclaire impactofcovid19pandemiconadultandpediatricallergyimmunologyservicesintheuknationalhealthservice |